Can ALA Ease MS Stress? Emerging Research Suggests “Yes”
Science has discovered some exciting benefits of alpha lipoic acid (ALA) for multiple sclerosis (MS). Research conducted by Oregon University of Health and Science and published in Multiple Sclerosis Journal reveals that ALA has the potential to reduce inflammation developed during the progression of the disease. Inflammation damages the body's cells, organs, and tissues, and it's linked to many other serious health conditions, such as cancer and cardiovascular disease. MS is classified as an autoimmune disorder—these types of diseases result from the immune system mistakenly attacking the body. Essentially, the immune system can no longer tell the difference between healthy tissues and dangerous substances like viruses, bacteria, and toxins.
When MS occurs, pro-inflammatory immune cells cross into the central nervous system and strike the myelin, a protective sheath that surrounds nerves. As it progresses, the disease can trigger paralysis, muscle stiffness, epilepsy, and depression.
With 400,000 Americans currently affected, MS is more prevalent in people of Northern European descent, and women are twice as likely as men to get it. Although people can develop MS at any age, most patients are diagnosed between the ages of 20 and 50.
Scientists are still trying to find the answer to an important, relevant question: What causes MS? At present, they believe environmental and genetic factors play a role in the onset of the disease. Because one of the key biological markers of MS is inflammation, it's not surprising that scientists turned to study alpha lipoic acid. It has already come to the attention of medical researchers because of its powerful